Article Information
History
- August 7, 2020.
Article Versions
- You are currently viewing Version 1 of this article (August 7, 2020 - 09:54).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Roberto Pastor-Barriuso†,a,b,
- Beatriz Pérez-Gómez†,a,b,
- Miguel A. Hernánc,
- Mayte Pérez-Olmedad,
- Raquel Yottie,
- Jesús Oteod,f,
- Jose L Sanmartíng,
- Inmaculada León-Gómeza,b,
- Aurora Fernández-Garcíab,d,
- Pablo Fernández-Navarroa,b,
- Israel Cruzh,
- Mariano Martíng,
- Concha Delgado-Sanza,b,
- Nerea Fernández de Larreaa,b,
- Jose León Paniaguae,
- Juan F. Muñoz-Montalvog,
- Faustino Blancog,
- Amparo Larrauria,b,§,
- Marina Pollána,b,§,* and
- on behalf of the ENE-COVID Study Group‡
- aNational Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain
- bConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain
- cDepartments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health; Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA
- dNational Centre for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain
- eInstitute of Health Carlos III, Madrid, Spain
- fSpanish Network for Research in Infectious Diseases (REIPI), Institute of Health Carlos III, Madrid, Spain
- gMinistry of Health, Madrid, Spain
- hNational School of Public Health. Institute of Health Carlos III, Madrid, Spain
- ↵*Correspondence to: Prof. Marina Pollán, National Centre for Epidemiology, Institute of Health Carlos III, Monforte de Lemos 5, 28029 Madrid, Spain mpollan{at}isciii.es
Posted August 07, 2020.
